15 December 2014
ByAppeared in BioNews 784
A new type of stem cell has been developed in the lab, in research described as 'groundbreaking'.
The cells have been dubbed 'F-class' stem cells due to their 'fuzzy' appearance. They appear to multiply more rapidly and easily than other iPS cells, and they are produced when very high levels of transcription factors are added to adult cells. The researchers say it will be more economical to produce these F-class stem cells, which can be used for drug screening and disease modelling.
'We can put these cells into a big jar of media and grow them up in a suspension, which is much more efficient, cheaper, and less work to produce a huge number of cells,' said Dr Andras Nagy, who led the research.
The cells were identified during a project led by Mount Sinai Hospital’s Lunenfeld-Tanenbaum Research Institute. Scientists catalogued the stages a cell goes through as it is being reprogrammed, and in the process, uncovered a new 'state' of stem cell. Their research also highlighted the different properties that arise when certain cells and transcription factors are used.
'This project has been a real adventure for us into integrative biology in a new era of global science,' said Utrecht University's Dr Albert Heck, one of those involved in the research. 'Our group determined the faith of every protein during this process, picking up many known and novel markers for transitions to iPS cells and the new F-class stem cells.'
'What I find particularly exciting is that this opens up the idea that there may be different kinds of pluripotent stem cells,' Dr Paul Knoepfler, a stem cell biologist at the University of California, Davis, told The Scientist.
The extensive research was published in a series of five papers in Nature.